BRISBANE, Calif., Jan. 30, 2017 -- Cutera, Inc. (Nasdaq:CUTR) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, will announce financial results for the fourth quarter, and full-year 2016, on Monday, February 13th 2017 after market close. The Company will also host a conference call to discuss these results with additional comments and details. Participating on the call will be James Reinstein, President and Chief Executive Officer, and Ron Santilli, Executive Vice President and Chief Financial Officer.
The conference call is scheduled to begin at 2:00 p.m. PT (5:00 p.m. ET) on February 13th, 2017. The call will be broadcast live over the Internet, hosted at the Investor Relations section of Cutera's website at http://www.cutera.com/, and will be archived online within one hour of its completion through February 27, 2017. In addition, you may call 1-877-705-6003 to listen to the live broadcast.
About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
CONTACTS: Cutera, Inc. Ron Santilli Chief Financial Officer [email protected] Investor Relations John Mills Integrated Corporate Relations, Inc. [email protected] 646-277-1254


Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
FDA Approves Mitapivat for Anemia in Thalassemia Patients
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Italy Fines Apple €98.6 Million Over App Store Dominance
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 



